Hematology Malignancies Program: Our Physicians | Tampa General Hospital
Hematology Malignancies Program: Our Physicians
Eduardo Sotomayor, MD
Vice President, Executive Director, TGH Cancer Institute
Medical Director, Hematology Malignancy
Dr. Eduardo Sotomayor is the vice president and executive director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences.
Ivan Borrello, MD
Director, Bone Marrow Transplant & Cell Therapies Program
Hematologist Oncologist
Dr. Ivan M. Borrello is a hematologist oncologist and renowned physician-scientist who serves as Medical Director of the Myeloma, Bone Marrow Transplant (BMT) and Cell Therapies program within the TGH Cancer Institute. Fluent in English, Italian, Spanish and Portuguese, Dr. Borrello is recognized as a leader in the field of immunotherapy of hematologic malignancies (leukemias, lymphomas, multiple myeloma) as well as bone marrow and stem cell transplants.
David Swoboda, MD
Clinical Director of Leukemia
Malignant Hematologist, TGH Cancer Institute
Dr. David Swoboda is a hematologist-oncologist at Tampa General Hospital who specializes in malignant hematology. Prior to joining Tampa General, he was a chief hematology-oncology fellow at H. Lee Moffitt Cancer Center in Tampa after serving as a chief resident at Medstar Georgetown University Hospital in Washington, D.C. Dr. Swoboda enjoys developing a close relationship with his patients and their families, building trust and gaining a full understanding of each disease in order to provide personalized, comprehensive care. His research is directed toward acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative disorders. He has published several entries in peer-reviewed journals and has participated in numerous scientific abstract presentations.
Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in benign and malignant hematology as well as solid tumor oncology.
Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident.
Dr. Vijay Narendran, MD, MBA, trained in internal medicine at University Hospitals Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center in Cleveland. Dr. Narendran continued his graduate medical studies at New York University School of Medicine by pursuing a clinical fellowship in hematology and medical oncology. Dr. Narendran later conducted research in hematologic malignancies and went on to become an assistant professor at Hofstra University School of Medicine in Hempstead, New York. Dr. Narendran also worked at Monter Cancer Center in North New Hyde Park, New York, focusing on hematologic malignancies such as leukemia and lymphoma, and a variety of benign blood disorders. Before joining the Cancer Center of South Florida, Dr. Narendran also practiced medicine in the Pacific Northwest, working primarily in cancers of the lung, and the head and neck.
Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.
Before joining the Cancer Center of South Florida, Raymond Tsao, MD, served as an assistant professor at the University of North Carolina, where his duties included cancer care, medical education and enrolling patients in clinical trials. His research on pancreatic cancer and lymphoma has been published and presented during national cancer meetings. Dr. Tsao completed his fellowship in hematology and medical oncology at The Cleveland Clinic Foundation in Cleveland, and has been a member of multiple national cancer research organizations, including Southwest Oncology Group and National Surgical Adjuvant Breast and Bowel Project.
Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.
